GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
M

Medinet Co 2370.T · JPY

Health Care · Tokyo Stock Exchange · 🇯🇵 Japan

Compare

17

0.00%

Close of 9 Nov 2026, in JPY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in JPY, from our data supplier.

FY2025

Revenue

¥810.3m

FY2016FY2025

Net income

−¥1.36bn

FY2016FY2025

Free cash flow

−¥1.44bn

FY2016FY2025

Shareholders' equity

¥3.78bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue¥810.3m¥768.5m¥661.5m¥633.7m¥683.0m¥783.0m¥1.06bn¥998.3m¥1.70bn¥1.91bn
Gross profit¥83.4m¥82.7m¥65.2m¥90.4m¥135.5m¥229.7m¥296.1m¥330.0m¥769.1m¥860.7m
Research and development¥452.5m¥452.8m¥496.7m¥565.2m¥325.7m¥250.0m¥276.6m¥1.50bn¥612.5m¥603.4m
Operating income−¥1.45bn−¥1.35bn−¥1.43bn−¥1.33bn−¥833.4m−¥926.1m−¥1.01bn−¥3.03bn−¥1.80bn−¥1.68bn
Net income−¥1.36bn−¥1.28bn−¥1.44bn−¥1.25bn−¥843.4m−¥842.0m−¥795.3m−¥3.05bn−¥2.60bn−¥1.64bn
Diluted earnings per share-5.15-4.83-5.90-5.92-4.64-5.12-6.44-25.76-23.90-17.73

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets¥4.25bn¥5.70bn¥5.63bn¥6.08bn¥5.38bn¥5.25bn¥3.08bn¥3.94bn¥6.27bn¥7.65bn
Cash and short-term investments¥3.17bn¥4.65bn¥4.40bn¥4.50bn¥4.10bn¥3.64bn¥1.40bn¥2.20bn¥3.44bn¥3.59bn
Total liabilities¥477.1m¥510.0m¥590.6m¥566.6m¥475.4m¥443.5m¥494.2m¥624.1m¥785.6m¥1.72bn
Debt—¥781,000¥2.3m¥4.3m¥7.7m¥16.5m¥33.0m¥73.4m¥127.7m¥1.04bn
Shareholders' equity¥3.78bn¥5.19bn¥5.04bn¥5.51bn¥4.90bn¥4.81bn¥2.59bn¥3.31bn¥5.48bn¥5.93bn
Shares outstanding265m265m244m212m182m164m124m118m109m93m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−¥1.41bn−¥1.19bn−¥1.26bn−¥1.13bn−¥612.1m−¥547.5m−¥917.1m−¥2.50bn−¥1.33bn−¥1.09bn
Capital spending−¥22.9m−¥53.6m−¥20.5m−¥13.8m−¥21.4m−¥17.7m−¥105.7m−¥215.4m−¥2.5m−¥16.8m
Free cash flow−¥1.44bn−¥1.25bn−¥1.28bn−¥1.14bn−¥633.5m−¥565.2m−¥1.02bn−¥2.71bn−¥1.34bn−¥1.10bn
Dividends paid——−¥2.0m−¥3.4m——————

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue¥195.8m¥232.9m¥181.2m¥237.5m¥168.0m¥200.4m¥204.4m¥179.0m
Gross profit¥59.5m¥93.7m¥22.8m¥44.6m¥6.1m¥33.3m¥25.7m¥5.9m
Operating income−¥299.7m−¥258.7m−¥371.1m−¥300.1m−¥389.5m−¥372.1m−¥380.6m−¥355.8m
Net income−¥294.0m−¥212.1m−¥339.3m−¥250.3m−¥406.2m−¥360.0m−¥345.6m−¥325.6m
Diluted earnings per share-1.05-0.76-1.28-0.95-1.53-1.36-1.31-1.23
Total assets¥3.79bn¥3.99bn¥3.95bn¥4.25bn¥4.50bn¥5.44bn¥5.30bn¥5.70bn
Cash and short-term investments¥2.71bn¥2.93bn¥2.85bn¥3.17bn¥3.56bn¥3.85bn¥4.16bn¥4.65bn
Debt———————¥781,000
Shareholders' equity¥3.39bn¥3.57bn¥3.43bn¥3.78bn¥4.02bn¥4.43bn¥4.82bn¥5.19bn

Financial ratios

Data as of 8 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Gross margin10.3%10.8%9.9%14.3%19.8%29.3%—
Operating margin-167.6%-165.7%-215.9%-197.1%-122.0%-118.3%—
Net margin-168.1%-166.2%-217.4%-197.9%-123.5%-107.5%—
Return on equity-36.1%-24.6%-28.5%-22.8%-17.2%-17.5%—
Return on assets-32.0%-22.4%-25.5%-20.6%-15.7%-16.0%—
Free cash flow yield-21.9%-18.0%-21.2%-22.0%-13.5%-13.4%—
Revenue growth5.4%16.2%4.4%-7.2%-12.8%-26.1%—
Earnings growth6.7%-11.2%14.7%48.7%0.2%5.9%—
Current ratio15.49x18.64x13.75x17.21x16.02x14.40x—
Debt to equity—0.00x0.00x0.00x0.00x0.00x0.01x
Equity ratio88.8%91.1%89.5%90.7%91.2%91.6%—
Interest coverage-193988.71x-47153.85x-248.23x-12741.76x-180.00x-105.48x—
R&D as a share of sales55.8%58.9%75.1%89.2%47.7%31.9%—
Buybacks as a share of market value-0.1%-8.5%-15.1%-16.4%-10.6%-33.1%—

Growth per year

Compound annual rate

3 years5 years10 years
Revenue8.5%0.7%-7.0%
Operating income2.7%9.3%-1.8%
Net income2.8%10.1%-2.3%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin10.5%11.2%15.8%30.9%
Operating margin-176.9%-193.2%-168.5%-141.9%
Net margin-167.2%-185.5%-161.7%-143.9%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings-5.6-7.5-7.3-12.0-10.8-11.5-9.6-2.5-5.4-7.8
Price to sales9.512.415.823.713.312.47.27.58.36.8

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 100-for-1 split · 27 Mar 2014
  • 10-for-1 split · 25 Nov 2003

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.